Post-hoc Analysis of the Effects of Belimumab on Musculoskeletal Organ Manifestations in BILAG in the Phase-3-Trials with Belimumab

被引：0
|
作者：
Hiepe, F. [1 ]
Fischer-Betz, R. [2 ]
Schwarting, A. [3 ,4 ]
机构：
[1] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-13353 Berlin, Germany
[2] Univ Dusseldorf, Poliklin Rheumatol, Dusseldorf, Germany
[3] Univ Mainz Klinikum, Bad Kreuznach, Germany
[4] ACURA Rheumazentrum Rheinland Pfalz AG, Bad Kreuznach, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [41] Dulaglutide treatment reduces glycaemic excursions in people with type 2 diabetes: a post-hoc analysis of 6 phase 3 randomised clinical trials
    Pechtner, V.
    Charpentier, G.
    Garcia-Perez, L. -E.
    Thieu, V. T.
    Jia, N.
    Jacobson, J. G.
    DIABETOLOGIA, 2017, 60 : S386 - S386
  • [42] EFFICACY OF TOFACITINIB BY BACKGROUND METHOTREXATE DOSE IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST-HOC ANALYSIS OF POOLED DATA FROM 2 PHASE 3 TRIALS
    Kivitz, A. J.
    FitzGerald, O.
    Nash, P.
    Pang, S.
    Azevedo, V. F.
    Kudlacz, E.
    Wang, C.
    Graham, D.
    Takiya, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1575 - 1575
  • [43] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, P.
    Downie, B.
    Liu, J.
    Hawtin, R.
    Curtis, J. R.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 502 - 502
  • [44] Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States
    Varnado, Oralee J.
    Ye, Wenyu
    Mi, Xiaojuan
    Burge, Russel
    Hall, Jerry
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 149 - 157
  • [45] Dulaglutide Treatment Reduces Glycemic Excursions in People with Type 2 Diabetes: A Post-hoc Analysis of Six Phase 3 Randomized Clinical Trials
    Charpentier, Guillaume
    Garcia-Perez, Luis E.
    Thieu, Vivian T.
    Jia, Nan
    Jacobson, Jennie G.
    Pechtner, Valeria
    DIABETES, 2017, 66 : A623 - A623
  • [46] EFFICACY OF MIRABEGRON IN OVERACTIVE BLADDER PATIENTS STRATIFIED BY SEVERITY OF BASELINE INCONTINENCE: A POST-HOC ANALYSIS OF POOLED DATA FROM 3 RANDOMISED PHASE 3 TRIALS
    Chapple, C. R.
    Khullar, V.
    Nitti, V. W.
    Herschorn, S.
    Kaper, M.
    Dorrepaal, C.
    Martin, N.
    Siddiqui, E.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 : S12 - S13
  • [47] Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data
    Jin, Jie
    Wu, Depei
    Liu, Yang
    Pan, Sisi
    Yan, Jean Li
    Aram, Jalal A.
    Lou, Yin-jun
    Meng, Haitao
    Chen, Xiaochen
    Zhang, Xian'an
    Schwartz, Ilan S.
    Patterson, Thomas F.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [48] Efficacy of zonisamide on motor symptoms in dementia with Lewy bodies: A post-hoc analysis of a phase 3 study
    Maruyama, H.
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Kosaka, K.
    MOVEMENT DISORDERS, 2018, 33 : S13 - S14
  • [49] Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data
    Jie Jin
    Depei Wu
    Yang Liu
    Sisi Pan
    Jean Li Yan
    Jalal A. Aram
    Yin-jun Lou
    Haitao Meng
    Xiaochen Chen
    Xian’an Zhang
    Ilan S. Schwartz
    Thomas F. Patterson
    BMC Infectious Diseases, 19
  • [50] Certolizumab Inhibits Radiographic Progression Even in RA Patients with High Rheumatoid Factor Levels: A Pooled, Post-Hoc Analysis of Two Phase 3 Trials
    Smolen, Josef
    Burmester, Gerd
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Curtis, Jeffrey
    Mikuls, Ted
    Lopez Medina, Clementina
    Taylor, Peter C.
    Tilt, Nicola
    Lauwerys, Bernard
    Ufuktepe, Baran
    Huizinga, Thomas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4597 - 4600
12345